Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

De-extinction startup Colossal Biosciences is in talks to raise capital at a valuation of twenty to thirty billion dollars, TechCrunch reports. The funding round would roughly double or triple the company's previous valuation.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton